This mechanism is related to the fact that E2F2 inhibited the proliferation of cancer cells by inhibiting the expression of survivin and regulating the expression of molecules such as cyclin A2, proto-oncogene C-Myc, minichromosome maintenance complex component 4 and cyclin dependent kinase 2 [41]. The gene discussed is MYC; the disease is cancer.